These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24446519)

  • 1. CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals.
    Bastidas S; Graw F; Smith MZ; Kuster H; Günthard HF; Oxenius A
    J Immunol; 2014 Feb; 192(4):1732-44. PubMed ID: 24446519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.
    Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N
    AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.
    Yue FY; Lo C; Sakhdari A; Lee EY; Kovacs CM; Benko E; Liu J; Song H; Jones RB; Sheth P; Chege D; Kaul R; Ostrowski MA
    J Immunol; 2010 Jul; 185(1):498-506. PubMed ID: 20519650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.
    Gougeon ML; Lecoeur H; Dulioust A; Enouf MG; Crouvoiser M; Goujard C; Debord T; Montagnier L
    J Immunol; 1996 May; 156(9):3509-20. PubMed ID: 8617980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease.
    Peritt D; Sesok-Pizzini DA; Schretzenmair R; Macgregor RR; Valiante NM; Tu X; Trinchieri G; Kamoun M
    J Immunol; 1999 Jun; 162(12):7563-8. PubMed ID: 10358213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
    Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
    Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.
    Sainz T; Serrano-Villar S; Díaz L; González Tomé MI; Gurbindo MD; de José MI; Mellado MJ; Ramos JT; Zamora J; Moreno S; Muñoz-Fernández MA
    AIDS; 2013 Jun; 27(9):1513-6. PubMed ID: 23435292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.
    Pacheco Y; Solé V; Billaud E; Allavena C; Plet A; Ferré V; Garrigue-Antar L; Raffi F; Jacques Y; McIlroy D
    AIDS; 2011 Sep; 25(14):1701-10. PubMed ID: 21673554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.
    Méndez-Lagares G; García-Pergañeda A; del Mar del Pozo-Balado M; Genebat M; Ruiz-Mateos E; García García M; Muñoz-Fernández MÁ; Pacheco YM; Leal M
    J Antimicrob Chemother; 2012 May; 67(5):1228-37. PubMed ID: 22287235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA
    AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
    Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
    AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy.
    Gu XX; Yue FY; Kovacs CM; Ostrowski MA
    PLoS One; 2007 Mar; 2(3):e300. PubMed ID: 17375186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.